The contractor shall provide niaid with a broad and flexible range of capabilities that are required for preclinical and translational development support for promising vaccines and related products…
Active Awarded Last action
- Contract number
- 75N93022D00007
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $1,428,706 obligated
Award facts
- Opportunity
-
- Preclinical and translational vaccine development for HIV and other candidate agents Pre-Solicitation · 75N93019R00023 · Posted Mar 26, 2020
- Combined order value
-
- $1,428,706 Current, with exercised options
- $2,154,144 Potential, with all options
- Last date to order 70% complete
- IDV ceiling <1% used
- $364,553,934.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded multiple Indefinite Delivery/Indefinite Quantity contracts to support preclinical and translational vaccine development services for HIV vaccines and other candidate agents. The total potential value of the contracts is $364,553,934 over a seven-year period of performance from December 2021 through November 2028.
The contracts will provide a broad range of capabilities required for preclinical and translational development support, including product storage and shipping, safety and immunogenicity studies, feasibility assessments, analytical development, process development, cGMP manufacturing, stability testing, fill-finish, and scientific/quality support services. Task Area G for scientific, quality, and regulatory support services is set aside for small business concerns. Sri International is the prime contractor.
Immediately upon award, two cost-reimbursement task orders were issued. Task Order #A-1 requires 1.45 full-time equivalents for research and development product shipping and storage services from June 2021 through June 2022, with options to extend the term up to seven total years. The contracts aim to support the full range of preclinical and clinical activities necessary to advance promising vaccines and related products for HIV and other infectious diseases from initial development through clinical trials and product licensure.
Description
The contractor shall provide niaid with a broad and flexible range of capabilities that are required for preclinical and translational development support for promising vaccines and related products for HIV and other candidate agents. The contractor
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| GLP toxicology study for adjuvanted HIV-1 immunogen vaccine candidates | National Institute of Allergy and Infectious Diseases (NIH) | $1,428,706 |
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| VDX | $41,598 | |
| Antech Diagnostics, Inc. | $30,833 | |
| Charles River Laboratories, Inc. | $58,476 |
Quick answers
Who was awarded contract 75N93022D00007?
75N93022D00007 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2021.
How much is contract 75N93022D00007 worth?
Orders under 75N93022D00007 have obligated $1,428,706. Their combined potential value, with all options, is $2,154,144. 75N93022D00007's own ceiling is $364,553,934.
How many orders have been placed under contract 75N93022D00007?
1 order has been placed under 75N93022D00007, the latest on August 1, 2024.
Who can order from contract 75N93022D00007?
75N93022D00007 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93022D00007 part of a contract vehicle?
Yes. 75N93022D00007 is part of Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents.
Was contract 75N93022D00007 competed?
The extent of competition for 75N93022D00007 was full and open competition. The government received 9 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV